History of the Hub

The Global AMR R&D Hub facilitates international cross-sector collaboration in antimicrobial resistance research and development, fostering innovation to safeguard global health. Read our history on this page.

Following the adoption of the ‘Global Action Plan on Antimicrobial Resistance’ in 2015, the 2016 Political Declaration of the High-Level meeting of the United Nations General Assembly on AMR and ‘The Review on Antimicrobial Resistance’ also in 2016, there was a growing awareness of the need for increased coordination of investments in Antimicrobial Resistance (AMR) research and development (R&D) to help prioritise the development of the products, tools and strategies with the highest potential societal impact. Recognizing the necessity to prevent overlaps and duplicative efforts in AMR R&D given limited resources and finite funds, a call was made by G20 leaders in 2017 for the establishment of a new international R&D collaboration Hub.

The Global AMR R&D Hub was launched in May 2018 during the World Health Assembly and commenced operations in January 2019, with the establishment of a dedicated Secretariat in Berlin to oversee administrative planning and implementation.

Subscribe to our newsletter

You can sign up for our newsletter here. By subscribing, you automatically provide your consent for the use of your data in accordance with our privacy policy.

This field is for validation purposes and should be left unchanged.
Dynamic Dashboard